Clinical Trials Logo

Clinical Trial Summary

A multi-center, randomized, double-blind, parallel, active-controlled phase III clinical trial to evaluate the efficacy and safety of 'GLA5PR GLARS-NF1 Tab.' and 'Pregabalin' in peripheral neuropathic pain


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03221907
Study type Interventional
Source Daewon Pharmaceutical Co., Ltd.
Contact
Status Completed
Phase Phase 3
Start date April 11, 2016
Completion date January 8, 2019